Lanxess (ETR:LXS) received a €66.00 ($81.48) price target from equities researchers at Barclays in a note issued to investors on Thursday. The firm presently has a “neutral” rating on the stock. Barclays’ price target indicates a potential downside of 2.11% from the company’s current price.
Other analysts have also recently issued reports about the company. UBS Group set a €75.00 ($92.59) price target on Lanxess and gave the stock a “buy” rating in a research report on Monday. Macquarie set a €75.00 ($92.59) price target on Lanxess and gave the stock a “buy” rating in a research report on Thursday, October 26th. Morgan Stanley set a €64.00 ($79.01) price target on Lanxess and gave the stock a “neutral” rating in a research report on Wednesday, December 20th. DZ Bank reissued a “buy” rating on shares of Lanxess in a research report on Wednesday, December 13th. Finally, Deutsche Bank set a €69.00 ($85.19) price target on Lanxess and gave the stock a “neutral” rating in a research report on Wednesday, December 13th. Fourteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of €71.29 ($88.01).
Shares of Lanxess (ETR LXS) opened at €67.42 ($83.23) on Thursday. Lanxess has a 12-month low of €59.89 ($73.94) and a 12-month high of €74.50 ($91.98). The company has a market capitalization of $6,120.00 and a P/E ratio of 44.65.
LANXESS Aktiengesellschaft develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in four segments: Advanced Intermediates, Performance Chemicals, High Performance Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemicals and coatings industries; fine chemicals as precursors and intermediates for pharmaceuticals, agrochemicals, and specialty chemicals industries; customer-specific specialties; and tire chemicals.
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.